Emerging Therapeutic Options for the Management of COPD

被引：10
作者：
Reid, Debra J. [1 ]
Pham, Nga T. [1 ]
机构：
[1] Northeastern Univ, Sch Pharm, Dept Pharm Practice, Boston, MA 02115 USA
来源：
CLINICAL MEDICINE INSIGHTS-CIRCULATORY RESPIRATORY AND PULMONARY MEDICINE | 2013年 / 7卷
关键词：
chronic obstructive pulmonary disease; COPD therapy; long-acting muscarinic agent; phosphodiesterase-4; inhibitor; long-acting beta(2)-agonist;
D O I：
10.4137/CCRPM.S8140
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and is projected to be the third by 2020. COPD is characterized by chronic airflow limitation caused by airway inflammation and parenchymal destruction that is usually progressive. Inhaled bronchodilators continue to be the mainstay of the current management of COPD. Safety and efficacy data of the recently approved medications including aclidinium, glycopyrronium, roflumilast, and indacaterol are reviewed here.
引用
收藏
页码：7 / 15
页数：9
相关论文
共 50 条
  • [41] Pathophysiology, Therapeutic Targets, and Future Therapeutic Alternatives in COPD: Focus on the Importance of the Cholinergic System
    Gomes, Felisbela
    Cheng, Shih-Lung
    BIOMOLECULES, 2023, 13 (03)
  • [42] Emerging Therapeutic Targets for Soft Tissue Sarcoma
    Smith, Jason L.
    Riedel, Richard F.
    CURRENT ONCOLOGY REPORTS, 2011, 13 (04) : 350 - 358
  • [43] Towards Personalized Management of Sarcopenia in COPD
    van Bakel, Sophie I. J.
    Gosker, Harry R.
    Langen, Ramon C.
    Schols, Annemie M. W. J.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 25 - 40
  • [44] Triple Therapy for the Management of COPD: A Review
    Gaebel, Kathryn
    McIvor, R. Andrew
    Xie, Feng
    Blackhouse, Gord
    Robertson, Diana
    Assasi, Nazila
    Hernandez, Paul
    Goeree, Ron
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2011, 8 (03) : 206 - 243
  • [45] The role of triple therapy in the management of COPD
    Calzetta, Luigino
    Matera, Maria Gabriella
    Rogliani, Paola
    Cazzola, Mario
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (08) : 865 - 874
  • [46] Approach to COPD management in Internal Medicine
    Martin-Escudero, J. C.
    REVISTA CLINICA ESPANOLA, 2010, 210 (04): : 171 - 177
  • [47] Emerging Therapeutic Targets of Neuroendocrine Prostate Cancer
    Zhu, Xiaolin
    Ding, Chien-Kuang C.
    Aggarwal, Rahul R.
    CURRENT ONCOLOGY REPORTS, 2025, : 362 - 374
  • [48] The implication of telehealthcare in COPD management of China
    Lao, Xiangda
    Zhang, Jing
    Bai, Chunxue
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2013, 7 (05) : 459 - 463
  • [49] Bronchoscopic Management of COPD and Advances in Therapy
    DeMarco, Benjamin
    MacRosty, Christina R.
    LIFE-BASEL, 2023, 13 (04):
  • [50] The Saudi Guidelines for the Diagnosis and Management of COPD
    Khan, Javed H.
    Lababidi, Hani M. S.
    Al-Moamary, Mohamed S.
    Zeitouni, Mohammed O.
    AL-Jahdali, Hamdan H.
    Al-Amoudi, Omar S.
    Wali, Siraj O.
    Idrees, Majdy M.
    Al-Shimemri, Abdullah A.
    Al Ghobain, Mohammed O.
    Alorainy, Hassan S.
    Al-Hajjaj, Mohamed S.
    ANNALS OF THORACIC MEDICINE, 2014, 9 (02) : 55 - 76
12345